LAB vs MKC · rev $174.4M vs P/E 8.4, $13.56B cap
Standard Biotools Inc (LAB) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
MKC does not have a complete income-statement cache yet.
LAB currently screens at market cap $317.1M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the LAB and MKC stock pages for the full models.
Not investment advice.